Literature DB >> 29991558

Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Amit Sud1,2, Subhayan Chattopadhyay2, Hauke Thomsen2, Kristina Sundquist3,4,5, Jan Sundquist3,4,5, Richard S Houlston1,6, Kari Hemminki2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29991558      PMCID： PMC6194341          DOI： 10.1182/blood-2018-06-858597

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Lynn R Goldin; Sigurdur Y Kristinsson; Xueying Sharon Liang; Asa R Derolf; Ola Landgren; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Disease anticipation in familial myeloproliferative neoplasms.

Authors:  Elisa Rumi; Francesco Passamonti; Cristina Picone; Matteo Giovanni Della Porta; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

3.  The nation-wide Swedish family-cancer database--updated structure and familial rates.

Authors:  K Hemminki; X Li; K Plna; C Granström; P Vaittinen
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

4.  Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

Authors:  Elisa Rumi; Francesco Passamonti; Matteo G Della Porta; Chiara Elena; Luca Arcaini; Laura Vanelli; Cecilia Del Curto; Daniela Pietra; Emanuela Boveri; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

5.  Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.

Authors:  David A Hinds; Kimberly E Barnholt; Ruben A Mesa; Amy K Kiefer; Chuong B Do; Nicholas Eriksson; Joanna L Mountain; Uta Francke; Joyce Y Tung; Huong Marie Nguyen; Haiyu Zhang; Linda Gojenola; James L Zehnder; Jason Gotlib
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.

Authors:  M Fallah; E Kharazmi; E Pukkala; S Tretli; J H Olsen; L Tryggvadottir; K Sundquist; K Hemminki
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

Review 8.  Genome-wide association studies of cancer: current insights and future perspectives.

Authors:  Amit Sud; Ben Kinnersley; Richard S Houlston
Journal:  Nat Rev Cancer       Date:  2017-10-13       Impact factor: 60.716

9.  Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.

Authors:  Jane E Churpek; Khateriaa Pyrtel; Krishna-Latha Kanchi; Jin Shao; Daniel Koboldt; Christopher A Miller; Dong Shen; Robert Fulton; Michelle O'Laughlin; Catrina Fronick; Iskra Pusic; Geoffrey L Uy; Evan M Braunstein; Mark Levis; Julie Ross; Kevin Elliott; Sharon Heath; Allan Jiang; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; John Welch; Richard Wilson; Timothy J Ley; Lucy A Godley; Timothy A Graubert
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

10.  The surprising implications of familial association in disease risk.

Authors:  Morten Valberg; Mats Julius Stensrud; Odd O Aalen
Journal:  BMC Public Health       Date:  2018-01-15       Impact factor: 3.295
View more
  14 in total

1.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

2.  CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Authors:  Yi Chen; Yang Zhang; Zhihua Wang; Yewei Wang; Yujiao Luo; Nannan Sun; Shasha Zheng; Wenzhe Yan; Xiang Xiao; Sufang Liu; Ji Li; Hongling Peng; Yunxiao Xu; Guoyu Hu; Zhao Cheng; Guangsen Zhang
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

3.  Family history of any cancer for childhood leukemia patients in Sweden.

Authors:  Xinjun Li; Kristina Sundquist; Jan Sundquist; Asta Försti; Kari Hemminki
Journal:  EJHaem       Date:  2021-05-03

Review 4.  The Microenvironment in Myeloproliferative Neoplasms.

Authors:  Gajalakshmi Ramanathan; Angela G Fleischman
Journal:  Hematol Oncol Clin North Am       Date:  2020-12-09       Impact factor: 3.722

Review 5.  Molecular pathogenesis of the myeloproliferative neoplasms.

Authors:  Graeme Greenfield; Mary Frances McMullin; Ken Mills
Journal:  J Hematol Oncol       Date:  2021-06-30       Impact factor: 17.388

6.  Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

Authors:  Tariq I Mughal; Michael W Deininger; Nicole Kucine; Giuseppe Saglio; Richard A Van Etten
Journal:  Hemasphere       Date:  2019-08-01

Review 7.  Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.

Authors:  Gajalakshmi Ramanathan; Brianna M Hoover; Angela G Fleischman
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.575

8.  Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.

Authors:  Evan M Braunstein; Hang Chen; Felicia Juarez; Fanghan Yang; Lindsay Tao; Igor Makhlin; Donna M Williams; Shruti Chaturvedi; Aparna Pallavajjala; Theodoros Karantanos; Renan Martin; Elizabeth Wohler; Nara Sobreira; Christopher D Gocke; Alison R Moliterno
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.639

9.  Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.

Authors:  Jean Pegliasco; Pierre Hirsch; Christophe Marzac; Françoise Isnard; Jean-Côme Meniane; Caroline Deswarte; Philippe Pellet; Céline Lemaitre; Gwendoline Leroy; Graciela Rabadan Moraes; Hélène Guermouche; Barbara Schmaltz-Panneau; Florence Pasquier; Chrystelle Colas; Patrick R Benusiglio; Odile Bera; Jean-Henri Bourhis; Eolia Brissot; Olivier Caron; Samy Chraibi; Pascale Cony-Makhoul; Christine Delaunay-Darivon; Simona Lapusan; Flore Sicre de Fontbrune; Pascal Fuseau; Albert Najman; William Vainchenker; François Delhommeau; Jean-Baptiste Micol; Isabelle Plo; Christine Bellanné-Chantelot
Journal:  Leukemia       Date:  2021-06-25       Impact factor: 11.528

10.  Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.

Authors:  Erik L Bao; Satish K Nandakumar; Xiaotian Liao; Alexander G Bick; Juha Karjalainen; Marcin Tabaka; Olga I Gan; Aki S Havulinna; Tuomo T J Kiiskinen; Caleb A Lareau; Aitzkoa L de Lapuente Portilla; Bo Li; Connor Emdin; Veryan Codd; Christopher P Nelson; Christopher J Walker; Claire Churchhouse; Albert de la Chapelle; Daryl E Klein; Björn Nilsson; Peter W F Wilson; Kelly Cho; Saiju Pyarajan; J Michael Gaziano; Nilesh J Samani; Aviv Regev; Aarno Palotie; Benjamin M Neale; John E Dick; Pradeep Natarajan; Christopher J O'Donnell; Mark J Daly; Michael Milyavsky; Sekar Kathiresan; Vijay G Sankaran
Journal:  Nature       Date:  2020-10-14       Impact factor: 69.504
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.